Results 1 to 10 of about 18,622 (204)

Dipyridamole activates adenosine A2B receptor and AMPK/cAMP signaling and promotes myogenic differentiation of myoblastic C2C12 cells

open access: yesFrontiers in Pharmacology, 2023
Introduction: Sarcopenia is defined as a loss of muscle mass and strength. ATP homeostasis is crucial during myogenesis. We determined how the purinergic system modulates myogenesis using dipyridamole (blocks adenosine taken up by the cells) and ...
Miguel Marco-Bonilla   +8 more
doaj   +2 more sources

Differentiating ischemic from healthy myocardium using cardiovascular magnetic resonance dipyridamole rest and stress T1 mapping [PDF]

open access: yesScientific Reports
Cardiovascular magnetic resonance (CMR) stress T1 mapping using adenosine and regadenoson can differentiate ischemic, infarcted, and healthy myocardium. However, the effect of dipyridamole remains unclear.
Yuan-Ting Chang   +9 more
doaj   +2 more sources

Effects of dipyridamole and its use in neurology

open access: yesМедицинский совет, 2021
Dipyridamole has been on the pharmaceutical market since 1959 and, as a pyrimidyl-pyrimidine compound, has a variety of mechanisms of action. The very first action of dipyridamole was its antianginal effect.
N. V. Pizova
doaj   +1 more source

High Grade AV Block Associated with Dipyridamole Infusion

open access: yesCase Reports in Clinical Practice, 2023
The use of dipyridamole for thallium imaging has proved very successful in demonstrating coronary arterial disease [1]. Dipyridamole causes coronary arteriolar vasodilation by increasing interstitial adenosine levels by inhibition of both adenosine ...
Mahdi Khalili   +3 more
doaj   +1 more source

Effect of Dipyridamole Injected for Myocardial Perfusion Imaging on Blood Glucose Concentration; A Preliminary Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Dipyridamole inhibits adenosine reuptake and increases cyclic Adenosine Monophosphate (cAMP) levels in platelets, erythrocytes and endothelial cells, all of which influence blood glucose.
Amirreza Khorasanchi   +7 more
doaj   +1 more source

Discovery of Dipyridamole Analogues with Enhanced Metabolic Stability for the Treatment of Idiopathic Pulmonary Fibrosis

open access: yesMolecules, 2022
Dipyridamole, apart from its well-known antiplatelet and phosphodiesterase inhibitory activities, is a promising old drug for the treatment of pulmonary fibrosis.
Meng-Xing Huang   +4 more
doaj   +1 more source

Dispersive micro solid phase extraction based on surface magnetic molecular imprinted polymer and deep eutectic solvent with optimization by central composite design for determination of dipyridamole in pharmaceutical and biological samples [PDF]

open access: yesشیمی کاربردی روز, 2021
In this work, a simple and inexpensive dispersive micro solid-phase extraction method using magnetic molecular imprinted polymer nanocomposite and deep eutectic solvent and optimization by central compound design method was developed for selective ...
Roya Mirzajani, Sara Karami
doaj   +1 more source

Spectroscopic and Fluorometric Determination of Cinnarizine and Dipyridamole in Pharmaceutical Tablets Using Eosin Y Dye [PDF]

open access: yesمجلة التربية والعلم, 2013
Spectrophotometric and spectrofluorimetric methods were developed for the determination of cinnarizine and dipyridamole. The spectrophotometric method is based on the formation of ion pair complex  between the studied drugs and eosin Y which shows ...
Zeina Al - Abdali, Elham Saleh
doaj   +1 more source

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study

open access: yesFrontiers in Neurology, 2018
Background and Purpose: No previous study has compared the impact of dipyridamole-based triple antiplatelet therapy on secondary stroke prevention and long-term outcomes to that of dual antiplatelet therapy (DAPT) in patients with acute myocardial ...
Mei-Tzu Wang   +20 more
doaj   +1 more source

Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease

open access: yesKaohsiung Journal of Medical Sciences, 2014
Dipyridamole has been shown to decrease proteinuria and improve renal function progression especially in early chronic kidney disease (CKD) patients with glomerulonephropathy.
Chi-Chih Hung   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy